| Thrombelastography‐guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial L De Pietri, M Bianchini, R Montalti, N De Maria, T Di Maira, B Begliomini, ... Hepatology 63 (2), 566-573, 2016 | 405 | 2016 |
| Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis L Turco, G Garcia-Tsao, I Magnani, M Bianchini, M Costetti, C Caporali, ... Journal of hepatology 68 (5), 949-958, 2018 | 131 | 2018 |
| Liver Angiopoietin‐2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct‐Acting Antivirals F Faillaci, L Marzi, R Critelli, F Milosa, F Schepis, E Turola, S Andreani, ... Hepatology 68 (3), 1010-1024, 2018 | 123 | 2018 |
| EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis E Villa, M Bianchini, A Blasi, A Denys, EG Giannini, A de Gottardi, ... Journal of hepatology 76 (5), 1151-1184, 2022 | 107 | 2022 |
| Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis E Turola, S Petta, E Vanni, F Milosa, L Valenti, R Critelli, L Miele, L Maccio, ... Disease models & mechanisms 8 (9), 1037-1046, 2015 | 91 | 2015 |
| Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease A Sartini, S Gitto, M Bianchini, MC Verga, M Di Girolamo, A Bertani, ... Cell death & disease 9 (2), 87, 2018 | 89 | 2018 |
| Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis J Ferrusquía-Acosta, O Bassegoda, L Turco, E Reverter, M Pellone, ... Journal of hepatology 74 (4), 811-818, 2021 | 72 | 2021 |
| Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 E Villa, R Critelli, S Lasagni, A Melegari, A Curatolo, C Celsa, ... Blood advances 5 (3), 662-673, 2021 | 55 | 2021 |
| Thromboelastographic reference ranges for a cirrhotic patient population undergoing liver transplantation L De Pietri, M Bianchini, G Rompianesi, E Bertellini, B Begliomini World Journal of Transplantation 6 (3), 583, 2016 | 51 | 2016 |
| Prevention and management of bleeding risk related to invasive procedures in cirrhosis F Schepis, L Turco, M Bianchini, E Villa Seminars in Liver Disease 38 (03), 215-229, 2018 | 48 | 2018 |
| Low molecular weight heparin does not increase bleeding and mortality post‐endoscopic variceal band ligation in cirrhotic patients M Bianchini, G Cavani, A Bonaccorso, L Turco, F Vizzutti, A Sartini, S Gitto, ... Liver international 38 (7), 1253-1262, 2018 | 48 | 2018 |
| Relevance of spontaneous portosystemic shunts detected with CT in patients with cirrhosis S Nardelli, O Riggio, L Turco, S Gioia, M Puzzono, M Bianchini, L Ridola, ... Radiology 299 (1), 133-140, 2021 | 47 | 2021 |
| Coagulopathy in liver diseases: complication or therapy? M Bianchini, L De Pietri, E Villa Digestive Diseases 32 (5), 609-614, 2014 | 36 | 2014 |
| Point-of-care testing in liver disease and liver surgery L Abeysundara, SV Mallett, B Clevenger Seminars in Thrombosis and Hemostasis 43 (04), 407-415, 2017 | 25 | 2017 |
| Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: a validated prediction model F Vizzutti, C Celsa, V Calvaruso, M Enea, S Battaglia, L Turco, M Senzolo, ... Hepatology 77 (2), 476-488, 2023 | 21 | 2023 |
| Pretreatment with pegylated interferon prevents emergence of lamivudine mutants in lamivudine-naive patients: a pilot study E Villa, B Lei, G Taliani, A Graziosi, R Critelli, M Luongo, W Gennari, ... Antiviral therapy 14 (8), 1081-1087, 2009 | 14 | 2009 |
| Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome A Bedini, N De Maria, M Del Buono, M Bianchini, M Mancini, C Binda, ... Digestive and Liver Disease 48 (10), 1142-1147, 2016 | 10 | 2016 |
| Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis S Nardelli, O Riggio, F Marra, S Gioia, D Saltini, D Bellafante, V Adotti, ... Journal of Hepatology 80 (4), 596-602, 2024 | 8 | 2024 |
| Thrombelastography (TEG) decreases blood products requirement before invasive procedures in cirrhotic patients with coagulation tests derangement. A randomized controlled trial L De Pietri, M Bianchini, R Montalti, N De Maria, T Di Maira, B Begliomini, ... Digestive and Liver Disease 46, e5-e6, 2014 | 7 | 2014 |
| Procalcitonin is the best diagnostic and prognostic marker of sepsis in decompensated cirrhotic patients F Schepis, M Bianchini, I Ferretti, M Marino, S Bonfreschi, G Dattomo, ... Journal of Hepatology 52, S85-S85, 2010 | 6 | 2010 |
